Skip to content

Legence

US · LGN #1958 by market cap Listed 2025
32.31 -2.78 -7.92%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 33.51 -4.50%
After-hours 32.31 0.00%
88.9025.4132.312026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on LGN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is -33.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 3.3% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days D → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C+

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 55.2x Better than 8%
Forward P/E 10.0x Better than 80%
Price / Sales 0.6x Better than 88%
P/E vs own 5-yr range 100th pctl Better than 1%
Growth A+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 27.0% Better than 88%
Free cash flow CAGR (3Y) 584.0% Better than 100%
Profitability D+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 21.0% Better than 19%
Operating margin 3.6% Better than 30%
Net margin -2.3% Better than 22%
Return on equity -13.2% Better than 18%
Return on invested capital 0.7% Better than 30%
Momentum D-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -45.6% Better than 7%
6-month return -60.4% Better than 4%
12-month return (ex latest month) -11.5% Better than 21%
Distance below 52-week high 69.9% Better than 6%
Financial Health D+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.6x Better than 43%
Debt to assets 43.4% Better than 22%
Interest coverage 0.5x Better than 26%
Free cash flow / net income 105.6% Better than 42%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 88.9% Better than 72%
Upside to average target 160.7% Better than 91%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.69%
1M -21.63%
3M -46.22%
6M -60.82%
YTD -24.93%
1Y -21.12%

Key statistics

Price & volume

Prev close
35.09
Open
33.51
Day range
31.76 - 34.99
Avg price
32.50
Volume
1.49M
Turnover
48.28M
Amplitude
9.21%
52-week range
23.90 - 107.24

Valuation

P/E
-34.52
P/E (TTM)
55.23
P/B
3.66
EPS
-0.94
Net profit
-72.41M
Net assets
682.52M

Share structure

Market cap
2.50B
Float cap
1.87B
Shares out
77.36M
Float shares
57.79M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2025-09-12
52-week range 10% of range
23.90 107.24

69.9% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-16.00M net over the window

Short interest

Shares short
2.56M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Legence (LGN)?

Legence last traded at 32.31. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Legence's market cap?

About 2.50B.

What is the P/E ratio of Legence?

The trailing twelve-month P/E is 55.23. The Valuation tab shows it against the stock's own five-year range.

Does Legence pay a dividend?

Legence does not currently pay a regular dividend.

Is Legence a buy according to analysts?

The consensus of 9 analysts is a Buy rating, with an average 12-month price target of 84.22, which implies 160.7% upside from the current price. This is not investment advice.

What is Legence's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Legence a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Legence discussion 0 comments

Add a comment